|
Volumn 3, Issue 1, 2005, Pages 71-72
|
Ostomy care: The added considerations for cancer patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
VASCULOTROPIN INHIBITOR;
ACCESS TO INFORMATION;
BONE MARROW SUPPRESSION;
CANCER PATIENT;
COLOSTOMY;
CONSTIPATION;
DIARRHEA;
DIGESTIVE SYSTEM CANCER;
DISEASE SEVERITY;
HUMAN;
ILEOSTOMY;
INDEPENDENCE;
INTESTINE PERFORATION;
MEDICAL DECISION MAKING;
PATIENT CARE;
PATIENT EDUCATION;
PATIENT MONITORING;
PERSONAL HYGIENE;
PRACTICE GUIDELINE;
QUALITY OF LIFE;
REVIEW;
SKIN CARE;
STOMATITIS;
URINARY DIVERSION;
UROGENITAL TRACT CANCER;
WOUND CARE;
WOUND HEALING;
WOUND HEALING IMPAIRMENT;
BLADDER TUMOR;
COLORECTAL TUMOR;
COMPARATIVE STUDY;
CYSTOSTOMY;
FEMALE;
FOLLOW UP;
ILEITIS;
MALE;
METHODOLOGY;
NOTE;
PEER REVIEW;
POSTOPERATIVE COMPLICATION;
RISK ASSESSMENT;
COLORECTAL NEOPLASMS;
COLOSTOMY;
CYSTOSTOMY;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
PEER REVIEW;
POSTOPERATIVE COMPLICATIONS;
POUCHITIS;
QUALITY OF LIFE;
RISK ASSESSMENT;
URINARY BLADDER NEOPLASMS;
URINARY DIVERSION;
|
EID: 15544378688
PISSN: 15446794
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (3)
|